- Home
- MDJH vs APM Comparison
MDJH vs APM Comparison
Compare MDJH & APM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDJH
- APM
- Stock Information
- Founded
- MDJH 2002
- APM 2010
- Country
- MDJH United Kingdom
- APM United Kingdom
- Employees
- MDJH N/A
- APM N/A
- Industry
- MDJH Real Estate
- APM Biotechnology: Pharmaceutical Preparations
- Sector
- MDJH Finance
- APM Health Care
- Exchange
- MDJH Nasdaq
- APM Nasdaq
- Market Cap
- MDJH 9.8M
- APM 9.8M
- IPO Year
- MDJH 2019
- APM 2018
- Fundamental
- Price
- MDJH $0.18
- APM $0.78
- Analyst Decision
- MDJH
- APM
- Analyst Count
- MDJH 0
- APM 0
- Target Price
- MDJH N/A
- APM N/A
- AVG Volume (30 Days)
- MDJH 14.0M
- APM 25.7K
- Earning Date
- MDJH 01-01-0001
- APM 12-20-2024
- Dividend Yield
- MDJH N/A
- APM N/A
- EPS Growth
- MDJH N/A
- APM N/A
- EPS
- MDJH N/A
- APM N/A
- Revenue
- MDJH $114,849.00
- APM $431,378.00
- Revenue This Year
- MDJH N/A
- APM $157,729.10
- Revenue Next Year
- MDJH N/A
- APM N/A
- P/E Ratio
- MDJH N/A
- APM N/A
- Revenue Growth
- MDJH 289.97
- APM N/A
- 52 Week Low
- MDJH $0.14
- APM $1.09
- 52 Week High
- MDJH $1.90
- APM $17.49
- Technical
- Relative Strength Index (RSI)
- MDJH 27.57
- APM 16.33
- Support Level
- MDJH $0.16
- APM $1.21
- Resistance Level
- MDJH $0.33
- APM $1.37
- Average True Range (ATR)
- MDJH 0.04
- APM 0.11
- MACD
- MDJH -0.00
- APM -0.02
- Stochastic Oscillator
- MDJH 6.24
- APM 1.33
About MDJH MDJM LTD
MDJM Ltd is a real estate service company. The company provides real estate agency services to real estate developer clients, as well as real estate consulting services and independent training services on an as-needed basis. It offers consulting, marketing planning, advertising services, and sales strategies to real estate clients. The company income is derived from commission-based services and minimal consulting and other services. The company has two operating segments; the real estate agent services segment and the hospitality business segment. It derives a majority of its revenue from the People's Republic of China.
About APM Aptorum Group Limited
Aptorum Group Ltd clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. The company operates in two segments: Therapeutics and Non-Therapeutics. The projects are ALS-4, SACT-1, and RPIDD. It is also engaged in providing healthcare services.